Identification of Highly Potent and Selective Interleukin-1 Receptor Associates Kinase 4 (IRAK4) Degrader for the Treatment of Autoimmune Disease

September 21, 2021

European Protein Degradation Congress

Euro Prot Deg image
Area of Focus
Immunology
Programs
IRAK4 (KT-474)
Indications
Atopic Dermatitis (AD) Hidradenitis Suppurativa (HS)
Development Stage
Pre-clinical Data
Share
LinkedInXFacebookEmailCopy Link